Effect of Chronic Angiotensin II Type I Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Variables in Patients with Heart Failure

• References

• 1 Wright RA, Flapan AD, Alberti KGMM, Ludlam CA, Fox KAA. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol 1994; 24: 67-73.
• 2 Moriyama Y, Ogawa H, Oshima S, Takazoe K, Honda Y, Hirashima O, Arai H, Sakamoto T, Sumida H, Suefuji H, Kaikita K, Yasue H. Captopril reduced plasminogen activator inhibitor activity in patients after acute myocardial infarction. Jpn Circ J 1997; 61: 308-14.
• 3 Lottermoser K, Wostmann B, Weisser B, Hertfelder HJ, Schmitz U, Vetter H, Dusing R. Effects of captopril on fibrinolytic function in healthy humans. Eur J Med Res 1999; 4: 31-4.
• 4 Jansson JH, Boman K, Nilsson TK. Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction. Eur J Clin Pharmacol 1993; 44: 485-8.
• 5 Sakata K, Shirotani M, Yoshida H, Urano T, Takada Y, Takada A. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension. Am Heart J 1999; 137: 1094-9.
• 6 Goodfield NER, Newby DE, Ludlam CA, Flapan AD. Effects of acute angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation 1999; 99: 2983-5.
• 7 Brown NJ, Agirbasli MA, Williams GH. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32: 965-71.
• 8 Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P, Timmis AD. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease. effects of beta-adrenoceptor blockers and angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1998; 32: 1962-8.
• 9 Brown NJ, Agirbasli M, Vaughan DE. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 1999; 34: 285-90.
• 10 Zehetgruber M, Beckmann R, Gabriel H, Christ G, Binder BR, Huber K. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters. Thromb Res 1996; 83: 143-52.
• 11 Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Effect of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 1997; 96: 442-7.
• 12 Pedersen OD, Gram J, Jeunemaitre X, Bilaud E, Jespersen J. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis 1997; 8: 283-91.
• 13 Soejima H, Ogawa H, Yasue H, Suefuji H, Kaikita K, Nishiyima K. Effects of imadipril therapy on endogenous fibrinolysis in patients with recent myocardial infarction. Clin Cardiol 1997; 20: 441-5.